Shanghai Shen Lian Biomedical Corp Total Assets
Shanghai Shen Lian Biomedical Corp total assets. Based on the latest financial reports, Shanghai Shen Lian Biomedical Corp (688098) holds total assets worth CN¥1.53 Billion CNY (≈ $223.88 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 688098 company net worth for the company's overall valuation and market capitalisation.
Total Assets of Shanghai Shen Lian Biomedical Corp (2013–2025)
Total assets of Shanghai Shen Lian Biomedical Corp from 2013 to 2025. This chart illustrates how Shanghai Shen Lian Biomedical Corp's total assets have evolved over time, based on quarterly financial data. See 688098 stock price and chart for real-time trading data and today's change.
Shanghai Shen Lian Biomedical Corp - Asset Composition Analysis
Shanghai Shen Lian Biomedical Corp Total Assets Breakdown (December 2025)
Shanghai Shen Lian Biomedical Corp total assets breakdown as of December 2025. Shanghai Shen Lian Biomedical Corp's total assets of CN¥1.53 Billion consist of 34.8% current assets and 65.3% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.9% |
| Accounts Receivable | CN¥282.11 Million | 18.3% |
| Inventory | CN¥94.47 Million | 6.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥140.10 Million | 9.1% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Shanghai Shen Lian Biomedical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore 688098 working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Shen Lian Biomedical Corp's current assets represent 34.8% of total assets in 2025, a decrease from 65.6% in 2013.
- Cash Position: Cash and equivalents constituted 7.9% of total assets in 2025, down from 41.8% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 1.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 18.3% of total assets.
Shanghai Shen Lian Biomedical Corp Competitors by Total Assets
Key competitors of Shanghai Shen Lian Biomedical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $10.03 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $752.18 Million |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Verona Pharma PLC ADR
NASDAQ:VRNA
|
USA | $572.87 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
Shanghai Shen Lian Biomedical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.00 | 4.22 | 6.65 |
| Quick Ratio | 3.11 | 3.50 | 5.99 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥371.31 Million | CN¥413.54 Million | CN¥604.97 Million |
Shanghai Shen Lian Biomedical Corp - Advanced Valuation Insights
This section examines the relationship between Shanghai Shen Lian Biomedical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.21 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | -0.8% |
| Total Assets | CN¥1.54 Billion |
| Market Capitalization | $433.25 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Shen Lian Biomedical Corp's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shanghai Shen Lian Biomedical Corp's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shanghai Shen Lian Biomedical Corp (2013–2025)
The table below shows the annual total assets of Shanghai Shen Lian Biomedical Corp from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.54 Billion ≈ $225.70 Million |
-0.76% |
| 2024-12-31 | CN¥1.55 Billion ≈ $227.42 Million |
-2.50% |
| 2023-12-31 | CN¥1.59 Billion ≈ $233.25 Million |
-0.69% |
| 2022-12-31 | CN¥1.61 Billion ≈ $234.87 Million |
+0.41% |
| 2021-12-31 | CN¥1.60 Billion ≈ $233.91 Million |
+5.55% |
| 2020-12-31 | CN¥1.51 Billion ≈ $221.61 Million |
+4.62% |
| 2019-12-31 | CN¥1.45 Billion ≈ $211.83 Million |
+42.89% |
| 2018-12-31 | CN¥1.01 Billion ≈ $148.25 Million |
+46.36% |
| 2017-12-31 | CN¥692.19 Million ≈ $101.29 Million |
+13.89% |
| 2016-12-31 | CN¥607.79 Million ≈ $88.94 Million |
+23.96% |
| 2015-12-31 | CN¥490.32 Million ≈ $71.75 Million |
-7.29% |
| 2014-12-31 | CN¥528.89 Million ≈ $77.39 Million |
-0.50% |
| 2013-12-31 | CN¥531.53 Million ≈ $77.78 Million |
-- |
About Shanghai Shen Lian Biomedical Corp
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.